An Autoimmune Mom’s Choice: Happiness As The Mom You Are
April 29, 2020
AARDA’s Statement on HHS Approval of Notice of Benefit and Payment Parameters Rule
May 8, 2020


The creators of the #GivingTuesday donation movement are sponsoring a unique day of action to support charities during the COVID-19 pandemic. Their call to action is critical and urgent.

Your participation in this special day of giving will help AARDA provide essential information and resources for people with autoimmune and related diseases during this global health care crisis.

Give Now

Specifically, AARDA is actively supporting some 50 million Americans with autoimmune and related diseases to better understand and safely access the best possible care for themselves and for their loved ones. We are far along in responding to questions raised by nearly 2,000 persons who participated in a series of recent national briefings and webinars concerning COVID-19.

AARDA is organizing key COVID-19 information and resources from public health organizations, patient group partners and health care organizations on our website. Our landing page is updated frequently, featuring breaking news, current research, and fresh links to trusted sources of expertise and guidance.

On April 3, 2020 AARDA, along with the NCAPG hosted, “National Briefing: CDC on COVID-19 & Autoimmune Disease.” A nationwide dialogue with leading medical experts on the COVID-19 coronavirus and its effects on people with autoimmune diseases.

On April 23, 2020 AARDA hosted, “National Webinar: Managing Stress and Promoting Well-Being in the Midst of the COVID-19 Pandemic.” Featuring perspectives from patients, practitioners, and coping tips from “Dr. Coping”, AARDA board member, Dr. Robert Phillips.

Please donate today to support AARDA’s unique and vital outreach to people living with autoimmune and related disease who are at risk of COVID-19 infection and serious illness. Your gift will enable us to make a positive, potentially life-saving difference in their lives.

Give Now

Thank you.

Leave a Reply

Your email address will not be published. Required fields are marked *